Sufentanil Citrate .05 mg/mL (Sufentanil Citrate INJECTION) .05 mg/mL

Sufentanil Citrate .05 mg/mL is a potent analgesic used for pain management. This injection is available in 5 mL ampules, with 10 ampules per carton. Learn more about its uses and effects.

Strength

.05 mg/mL

Pack Size

10 AMPULE in 1 CARTON (0641-6112-10) / 5 mL in 1 AMPULE (0641-6112-01)

Manufacturer / TM Owner

Hikma Pharmaceuticals USA Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Sufentanil Citrate .05 mg/mL is primarily used for pain relief, often administered epidurally or intravenously. It is commonly employed in surgical settings or for managing severe pain. What is Sufentanil Citrate used for? It is designed to provide effective analgesia during medical procedures or post-operative care.

Side Effects

Sufentanil Citrate .05 mg/mL is known for its strong analgesic properties, which help in managing pain. Common effects may include sedation and respiratory depression, which are typical of potent opioids. These effects are closely monitored by healthcare professionals to ensure patient safety.

Precautions & Warnings

Handling Sufentanil Citrate .05 mg/mL requires careful attention to dosage and administration. It should only be used under the supervision of a healthcare professional. Proper storage and disposal are essential to prevent misuse and ensure safety.

Avoid Interactions

Sufentanil Citrate .05 mg/mL may interact with other medications, including alcohol and certain antidepressants. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Always follow professional advice regarding its use.

Frequently Asked Questions

Sufentanil Citrate .05 mg/mL is used for pain management, often in surgical settings or for severe pain relief.

Sufentanil Citrate .05 mg/mL is typically administered epidurally or intravenously by healthcare professionals.

Common effects include sedation and respiratory depression, which are closely monitored by healthcare providers.

Sufentanil Citrate .05 mg/mL may interact with other medications, so it is important to consult a healthcare professional before use.

It should only be used under the supervision of a healthcare professional, and proper storage and disposal are essential.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.